We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RNLX market cap is 34.3M. The company's latest EPS is USD -0.2746 and P/E is -0.45.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 459k | 709k | 535k | 586k | 522k |
| Operating Income | -8.89M | -3.8M | -13.76M | -9.24M | -4.1M |
| Net Income | -10.15M | -9.13M | -7.1M | -7.07M | -4.73M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 339k | 1.49M | 2.97M | 3.4M | 2.29M |
| Operating Income | -10.8M | -34.72M | -57.24M | -32.19M | -31.89M |
| Net Income | -9.25M | -31.01M | -56.73M | -46.22M | -45.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.54M | 21.87M | 8.77M | 7.97M | 4.79M |
| Total Liabilities | 21.03M | 19.21M | 19.88M | 15.83M | 16.11M |
| Total Equity | -1.49M | 2.67M | -11.11M | -7.85M | -11.32M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.3M | 102.58M | 63.26M | 42.12M | 7.1M |
| Total Liabilities | 5.34M | 7.48M | 20.09M | 23.66M | 16.08M |
| Total Equity | 35.96M | 95.1M | 43.17M | 18.45M | -8.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.5M | -17.35M | -22.29M | -30.11M | -3.84M |
| Investing | N/A | N/A | -3k | -4k | 23k |
| Financing | -1.07M | -1.65M | 2.46M | 10.25M | N/A |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.06M | -24.63M | -45.75M | -32.67M | -29.83M |
| Investing | -849k | -741k | -694k | N/A | 117k |
| Financing | 16.85M | 77.24M | 25.52M | 15.12M | 10.09M |
| Market Cap | 34.3M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 8.88 |
| Price to Cash Ratio | 4.33 |
| Price to Book Ratio | -2.26 |
| Dividend Yield | - |
| Shares Outstanding | 165.6M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (15.22%) |
| Company Name | Renalytix PLC |
| Address |
2 leman street london E1W 9US |
| Website | https://renalytix.com |
| Industry | services, nec (8999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
